These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20701873)
1. Evaluation of interleukin-10 production in Pseudomonas aeruginosa induced acute pyelonephritis. Mittal R; Sharma S; Chhibber S; Harjai K J Infect Public Health; 2009; 2(3):136-40. PubMed ID: 20701873 [TBL] [Abstract][Full Text] [Related]
2. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Mittal R; Sharma S; Chhibber S; Harjai K Microb Pathog; 2008; 45(5-6):323-30. PubMed ID: 18771720 [TBL] [Abstract][Full Text] [Related]
3. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. Saini H; Vadekeetil A; Chhibber S; Harjai K Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194 [No Abstract] [Full Text] [Related]
4. Contribution of macrophage secretory products to urovirulence of Pseudomonas aeruginosa. Mittal R; Aggarwal S; Sharma S; Chhibber S; Harjai K FEMS Immunol Med Microbiol; 2009 Nov; 57(2):156-64. PubMed ID: 19735298 [TBL] [Abstract][Full Text] [Related]
5. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa. Bala A; Chhibber S; Harjai K Int J Med Microbiol; 2014 Nov; 304(8):1199-208. PubMed ID: 25240873 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Saini H; Chhibber S; Harjai K Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model. Sharma K; Bose SK; Chhibber S; Harjai K Inflammation; 2020 Dec; 43(6):2344-2356. PubMed ID: 32948964 [TBL] [Abstract][Full Text] [Related]
8. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity. Sabharwal N; Chhibber S; Harjai K Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605 [TBL] [Abstract][Full Text] [Related]
9. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model. Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo. Hengzhuang W; Høiby N; Ciofu O Methods Mol Biol; 2014; 1147():239-54. PubMed ID: 24664838 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion. Alhede M; Bjarnsholt T; Givskov M; Alhede M Adv Appl Microbiol; 2014; 86():1-40. PubMed ID: 24377853 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa. Mittal R; Sharma S; Chhibber S; Harjai K Can J Infect Dis Med Microbiol; 2009; 20(3):e35-42. PubMed ID: 20808454 [TBL] [Abstract][Full Text] [Related]
13. Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa. Mittal R; Sharma S; Chhibber S; Harjai K Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):12-26. PubMed ID: 16427697 [TBL] [Abstract][Full Text] [Related]
14. Quorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa. Gupta RK; Chhibber S; Harjai K Immunobiology; 2013 Feb; 218(2):181-5. PubMed ID: 22551929 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro. Pye CC; Yu AA; Weese JS Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965 [TBL] [Abstract][Full Text] [Related]
16. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model. Lu Q; Yu J; Bao L; Ran T; Zhong H Chemotherapy; 2013; 59(1):51-6. PubMed ID: 23816803 [TBL] [Abstract][Full Text] [Related]
17. Exploiting the antivirulence efficacy of an ajoene-ciprofloxacin combination against Pseudomonas aeruginosa biofilm associated murine acute pyelonephritis. Vadekeetil A; Saini H; Chhibber S; Harjai K Biofouling; 2016; 32(4):371-82. PubMed ID: 26930141 [TBL] [Abstract][Full Text] [Related]
18. Interactions of Pseudomonas aeruginosa in predominant biofilm or planktonic forms of existence in mixed culture with Escherichia coli in vitro. Kuznetsova MV; Maslennikova IL; Karpunina TI; Nesterova LY; Demakov VA Can J Microbiol; 2013 Sep; 59(9):604-10. PubMed ID: 24011343 [TBL] [Abstract][Full Text] [Related]
19. Shifting paradigms in Pseudomonas aeruginosa biofilm research. Tart AH; Wozniak DJ Curr Top Microbiol Immunol; 2008; 322():193-206. PubMed ID: 18453277 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. Tolker-Nielsen T APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]